Oral squamous cell carcinoma in cats: treatment, prognosis and clinical trials

Cats · USA & Canada

Understanding oral squamous cell carcinoma

Feline oral squamous cell carcinoma is usually an aggressive local cancer of the mouth. It often causes pain, difficulty eating and invasion of the tongue or jaw before distant spread becomes the main issue. Exact location, bone involvement and whether useful local control is anatomically possible are critical.

What does the prognosis look like?

The outlook is unfortunately often guarded. Typical survival times in published groups were about 1–2 months for mandibular, sublingual and maxillary tumors, about 5 months for oropharyngeal tumors, and about 5 months in one radiation-plus-carboplatin study. A small tumor that can be controlled completely may do much better. These figures explain why pain, eating and an oncology plan need attention now; supplements or home remedies should not delay that discussion.

What matters next

Move quickly to define the exact site, tumor size and whether jaw bone or the tongue is involved. Those findings determine whether meaningful local control is possible. Eating, pain, hydration and weight loss deserve active management immediately rather than waiting until the cancer plan is finalized.

Where are you now?

The oral tumor is still present and surgery is being considered

Define jaw, tongue and deep-tissue involvement before major surgery. The key question is whether complete removal is realistically possible with acceptable function, while pain and nutritional support are addressed at the same time.

Complete surgery is not feasible

Discuss radiation, investigational treatment, and symptom control together. The plan should explicitly address pain, eating, hydration, and tumor bleeding because local progression is often the immediate problem.

Eating or drinking is becoming difficult

Do not wait for the next routine oncology slot if the cat cannot maintain nutrition, hydration, or comfort. Supportive care may need to start before the definitive cancer plan is finalized.

Surgery has already been done

Review measured margins, bone involvement, and postoperative function. Incomplete removal may justify another local-control discussion rather than waiting for obvious regrowth.

If you are waiting for oncology

Pain, eating and local progression can become urgent in feline oral SCC. Obtain biopsy and local imaging quickly enough to decide whether meaningful surgery is possible; nutritional support should be planned early rather than after major weight loss.

Questions to ask your oncologist

How much jaw, tongue or deep tissue is involved?
Is complete surgery realistically possible with acceptable function?
What is the plan for pain control and nutrition if local control is limited?

How the diagnosis may appear in the record

The record should identify whether the tumor arises from the tongue, mandible, maxilla, tonsil, or another oral site and whether bone is invaded. CT and biopsy together are often more informative than “oral mass.” Margin measurements and lymph-node results matter when surgery is performed.

Changes to watch for at home

Drooling, mouth odor, pawing at the mouth, dropping food, hiding, reduced grooming, weight loss, or difficulty swallowing often reflect local pain and progression. Inability to eat or drink, uncontrolled bleeding, or breathing difficulty needs prompt care. Nutritional support should be discussed early.

How it is usually treated

Surgery offers the best chance of durable control only when complete removal is realistically possible. Radiation and other local treatments can be used when surgery is not feasible or for palliation. Pain control and nutritional support are often part of treatment from the beginning.

What can affect treatment choices

Tumor location, jaw or tongue involvement, bone invasion, ability to obtain useful local control, eating ability and pain are the most important treatment-changing factors.

Tests that may matter

Biopsy confirms the diagnosis, and CT is often useful for defining jaw, tongue and other local invasion before surgery or radiation. Regional lymph nodes may be sampled when staging would change treatment. Additional assays should have a clear practical purpose.

Treatment options available now

6 options currently in our catalog.

Check eligibility

RNA nanoparticle vaccine for feline oral squamous cell carcinoma

University of Florida · USA

Location

UF Small Animal Hospital, 2015 SW 16th Ave, Gainesville, FL 32608

Study details

Currently enrolling / limited enrollment

What is being offered: Histopathologic confirmation and staging imaging are required before screening, and UF Oncology must evaluate the cat. The protocol excludes advanced local or metastatic disease and major systemic comorbidities. Immune-modulating medications or supplements require investigator approval and may require a washout.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; No metastasis

May not qualify if: Advanced disease; Major systemic comorbidity

Costs / coverage: 🟡 Partially funded — the study covers all 3 vaccine-administration visits, associated examinations and pre/post bloodwork, immune monitoring, supportive care, 1- and 3-month rechecks, and any booster-vaccine administration. Owners pay for the initial study evaluation/diagnostics and standard SCC treatment, including surgery, chemotherapy or radiation.

Contact: UF Clinical Studies — complete the Study Interest Form on the official trial page; UF Oncology Staff: (352) 392-2235

Official study / enrollment information →

Palliative radiation + frunevetmab for feline bone-invasive oral SCC

University of Pennsylvania · USA

Location

Penn Vet Ryan Veterinary Hospital, 3900 Spruce St, Philadelphia, PA 19104

Study details

Active - Recruiting

What is being offered: Pilot palliative study for feline bone-invasive oral SCC.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; No metastasis; Mandibular or maxillary bone lysis; chemotherapy washout: 21 days; radiation washout: 21 days; Immunotherapy and anti ngf washout 21d

Costs / coverage: 🟠 Partially funded. Owners pay initial staging to establish eligibility, including the initial head CT, bloodwork and diagnostic cytology/histopathology of the oral mass and lymph nodes when needed. After enrollment, the study covers all six radiation treatments including anesthesia and examinations, Solensia/placebo and meloxicam, monitoring bloodwork, chest radiographs and the final head CT.

Contact: Penn Vet VCIC — vcic@vet.upenn.edu; 215-573-0302

Official study / enrollment information →

Gold nanoparticle photothermal treatment for selected superficial tumors

Bridge Animal Referral Center · USA

Location

Bridge Animal Referral Center, 8401 Main St, Edmonds, WA 98026, Edmonds, WA

Study details

Active enrollment — eligible superficial gross tumors

What is being offered: Intravenous gold nanoparticles followed by near-infrared laser heating of the superficial tumor; BARC describes one heat session for smaller lesions and commonly two to three for larger sarcomas.

Who may qualify: Active tumor required; Measurable

Costs / coverage: Current BARC enrollment page does not specify costs or coverage. An older BARC page mentions support for different, narrower cohorts; those amounts cannot be assumed to apply to this enrollment.

Contact: Bridge Animal Referral Center, Edmonds — 425-697-2272

Official study / enrollment information →

Porphysome nanoparticle phototherapy for feline oral squamous cell carcinoma

Ontario Veterinary College — University of Guelph · Canada

Location

Ontario Veterinary College, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada

Study details

Actively recruiting — listed on current OVC feline oncology trials page

What is being offered: Pilot treatment study using Porphysome liposome-based nanoparticles and phototherapy for cats with confirmed oral cavity squamous cell carcinoma. The current OVC feline oncology page lists the study as active; full protocol eligibility requires investigator prescreening.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required

Costs / coverage: No explicit current public breakdown of study-covered versus owner-paid costs was found. Confirm directly with OVC Clinical Trials.

Contact: OVC Clinical Trials — ovc.clinicaltrials@uoguelph.ca; official study contact form

Official study / enrollment information →

PIVOT-C intratumoral FVRCP vaccine therapy for feline oral tumors

NC State College of Veterinary Medicine · USA

Location

NC State Veterinary Hospital, 1052 William Moore Dr, Raleigh, NC 27607

Study details

Actively recruiting — enrollment finish December 31, 2027

What is being offered: 28-day pilot treatment study with weekly intratumoral FVRCP vaccine injections on days 0, 7, 14, 21 and 28. Cats cannot receive surgery or radiation while enrolled; those treatments may be considered after study completion or early exit.

Who may qualify: Active tumor required; Oral mass

May not qualify if: Concurrent surgery; Concurrent local radiation

Costs / coverage: Confirm study-covered and owner-paid costs with the investigator.

Contact: Dr. Joanne Intile / NC State — see official trial page

Official study / enrollment information →

Novel immunotherapy for cats with oral squamous cell carcinoma

Colorado State University Flint Animal Cancer Center · USA

Location

Flint Animal Cancer Center, 300 W Drake Rd, Fort Collins, CO 80523

Study details

Actively recruiting — listed on CSU current clinical trials page

What is being offered: Four intratumoral immunotherapy injections under anesthesia every three weeks, with CT and biopsies to assess response. Study ends at day 84; all visits at CSU.

Who may qualify: Confirmed cancer diagnosis required; Active tumor required; Accessible intratumoral target

May not qualify if: Immunosuppressive; Distant metastasis

Costs / coverage: 🟡 Partially funded. Screening support is available for CBC, chemistry, urine testing, lymph-node aspirates and chest radiographs. After acceptance, study examinations, blood tests, anesthesia, four immunotherapy injections, CT and biopsies are covered; up to $1,000 is available for study-related side effects. Owners pay cancer-diagnosis tests and any additional oncologist-recommended tests outside study coverage.

Contact: CSU Flint Animal Cancer Center Clinical Trials — (970) 297-4001; online clinical-trial consult form

Official study / enrollment information →